Erlanger Hires Structural Interventional Cardiologist Dr. Megan Coylewright Thursday, February 18, 2021 The Erlanger Heart and Lung Institute has added Megan Coylewright, MD, MPH, FSCAI, FACC, to its team of cardiology providers as director of the Structural Heart Program. In this role, Dr. Coylewright will lead a team that treats valvular and structural heart disease while expanding access to state-of-the-art cardiovascular device clinical trials in the region.
Dr. Coylewright is board-certified in the areas of cardiology and interventional cardiology. As a structural interventionalist, she performs minimally invasive valve repair and replacement, offering alternatives to traditional surgery. Her expertise includes transcatheter aortic valve replacement (TAVR), including expanded options for patients with diseased blood vessels or failed surgical valves.